Hyperglycemia promotes breast cancer progression by altering leptin/IGFR1 and Akt/mTOR signaling, whereas, in pancreatic cancer, it contributes to ROS stimulated cancer progression via suppression of the JNK and c-Jun pathways [141]. This evidence concerns the gene MTOR and Hyperglycemia.